These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1894378)

  • 21. Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi.
    Jobe DA; Callister SM; Lim LC; Lovrich SD; Schell RF
    J Clin Microbiol; 1994 Mar; 32(3):618-22. PubMed ID: 8195368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters.
    Du Chateau BK; England DM; Callister SM; Lim LC; Lovrich SD; Schell RF
    Infect Immun; 1996 Jul; 64(7):2540-7. PubMed ID: 8698477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.
    Schaible UE; Gern L; Wallich R; Kramer MD; Prester M; Simon MM
    Immunol Lett; 1993 May; 36(2):219-26. PubMed ID: 8349316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
    Lovrich SD; Callister SM; DuChateau BK; Lim LC; Winfrey J; Day SP; Schell RF
    Infect Immun; 1995 Jun; 63(6):2113-9. PubMed ID: 7768589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum complement sensitivity as a key factor in Lyme disease ecology.
    Kurtenbach K; Sewell HS; Ogden NH; Randolph SE; Nuttall PA
    Infect Immun; 1998 Mar; 66(3):1248-51. PubMed ID: 9488421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi.
    Barthold SW; Feng S; Bockenstedt LK; Fikrig E; Feen K
    Clin Infect Dis; 1997 Jul; 25 Suppl 1():S9-17. PubMed ID: 9233658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eliminating Factor H-Binding Activity of
    Marcinkiewicz AL; Lieknina I; Kotelovica S; Yang X; Kraiczy P; Pal U; Lin YP; Tars K
    Front Immunol; 2018; 9():181. PubMed ID: 29472926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.
    Barthold SW; Bockenstedt LK
    Infect Immun; 1993 Nov; 61(11):4696-702. PubMed ID: 8406868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.
    Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():141-6. PubMed ID: 12141738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active immunization of hamsters against experimental infection with Borrelia burgdorferi.
    Johnson RC; Kodner C; Russell M
    Infect Immun; 1986 Dec; 54(3):897-8. PubMed ID: 3781630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective activity of antisera against isolates of Borrelia burgdorferi from various geographical origins.
    Masuzawa T; Okada Y; Yanagihara Y
    Microbiol Immunol; 1993; 37(1):79-83. PubMed ID: 8474362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi.
    Kenefick KB; Lim LC; Alder JD; Schmitz JL; Czuprynski CJ; Schell RF
    J Infect Dis; 1993 May; 167(5):1086-92. PubMed ID: 8486941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
    Das S; Barthold SW; Giles SS; Montgomery RR; Telford SR; Fikrig E
    J Clin Invest; 1997 Mar; 99(5):987-95. PubMed ID: 9062357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depletion of complement has distinct effects on the primary and secondary antibody responses to a conjugate of pneumococcal serotype 14 capsular polysaccharide and a T-cell-dependent protein carrier.
    Test ST; Mitsuyoshi JK; Hu Y
    Infect Immun; 2005 Jan; 73(1):277-86. PubMed ID: 15618164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells.
    Fikrig E; Barthold SW; Chen M; Chang CH; Flavell RA
    J Immunol; 1997 Dec; 159(11):5682-6. PubMed ID: 9548512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of sera from patients with Lyme disease against Borrelia burgdorferi.
    Pavia CS; Wormser GP; Norman GL
    Clin Infect Dis; 1997 Jul; 25 Suppl 1():S25-30. PubMed ID: 9233660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease.
    McKisic MD; Barthold SW
    Infect Immun; 2000 Sep; 68(9):5190-7. PubMed ID: 10948143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.
    Schmitz JL; Schell RF; Lovrich SD; Callister SM; Coe JE
    Infect Immun; 1991 Jun; 59(6):1916-21. PubMed ID: 2037352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant.
    Kraiczy P; Hunfeld KP; Peters S; Würzner R; Acker G; Wilske B; Brade V
    J Med Microbiol; 2000 Oct; 49(10):917-928. PubMed ID: 11023189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprotective groups among isolates of Borrelia burgdorferi.
    Lovrich SD; Callister SM; Lim LC; Schell RF
    Infect Immun; 1993 Oct; 61(10):4367-74. PubMed ID: 8406827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.